Pappo, A. S., Kang, H. J., Macy, M. E., DuBois, S. G., Watt, T. C., Rossig, C., Vinti, L., Hayashi, R. J., Pathiraja, K., Singh, R., Gozman, A., Geoerger, B. (2025). Pembrolizumab in pediatric participants with relapsed or refractory microsatellite instability-high solid tumors: Results from the phase 1/2 KEYNOTE-051 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.10040